While humans have used medicinal fungi for thousands of years, modern research is just beginning to uncover their pharmacological properties. The main bioactive compounds in non-psychedelic mushrooms, like polysaccharides and terpenes, show promise for immunomodulatory, anti-inflammatory, and antioxidant effects. However, robust human trials are still limited, and these supplements carry real risks that require your clinical expertise.
This guide gives you the essential knowledge you need to counsel your patients effectively. You will learn which non-psychedelic mushrooms have evidence backing their use, which ones pose severe safety risks, and how to identify dangerous drug interactions. With this information, you can empower your patients to make safe, informed choices about their health.
Related CE course for pharmacists: Medicinal (Non-Psychedelic) Mushrooms
The difference between medicinal and psychedelic fungi
Medicinal mushrooms are used to enhance health or treat medical conditions. They do not cause hallucinations. Psychedelic mushrooms contain psychoactive compounds like psilocybin or ibotenic acid, which alter perception and cause hallucinations. The fly agaric mushroom, for example, is highly toxic and can cause severe neurological and psychiatric symptoms.
As a pharmacist or pharmacy assistant, your focus will mostly be on non-psychedelic mushrooms. Patients often buy these as over-the-counter extracts, powders, or capsules. Since these products lack strict regulatory oversight, you play a vital role in reviewing their safety and compatibility with prescription regimens.
Mushrooms with evidence for specific conditions
Most non-psychedelic mushrooms lack sufficient evidence to support their use for specific diseases. However, a few show promising clinical data for certain conditions, giving you an opportunity to educate patients on what actually works.
Turkey tail for cancer support
Turkey tail is one of the most studied non-psychedelic mushrooms. Its main bioactive polysaccharides, PSK and PSP, are used routinely in Japan and China alongside conventional cancer treatments. Research shows that taking PSK alongside chemotherapy might improve response rates and survival for patients with breast, gastric, colon, or rectal cancer.
However, you need to watch out for specific drug interactions. Animal research suggests turkey tail constituents can increase the concentration of cyclophosphamide and interfere with tamoxifen absorption. It also inhibits CYP2C9 enzymes in vitro. You should carefully review a patient’s oncology regimen before they start taking turkey tail supplements.
Cordyceps and kidney function
Cordyceps grows on insect larvae and is popular for fatigue and immune support. While it does not actually improve athletic performance, it does show some benefit for kidney health. Clinical studies suggest oral cordyceps can modestly improve renal function in patients with chronic kidney disease and diabetic nephropathy.
Patients on immunosuppressants, like those with a kidney transplant, need strict monitoring. Research is conflicting on whether cordyceps stimulates or suppresses the immune system, making it a risky choice for transplant recipients or patients with autoimmune diseases. It can also inhibit platelet aggregation, so advise patients to stop taking it two weeks before surgery.
Severe adverse effects and toxicity risks
While many non-psychedelic mushrooms are well-tolerated, some carry severe risks that you must communicate to your patients.
Hepatotoxicity
Certain mushrooms can cause severe liver damage. Agaricus blazei, used theoretically for diabetes and hyperlipidemia, has been linked to fatal, fulminant hepatitis in a few patients receiving chemotherapy. Reishi mushroom, often called the “mushroom of immortality,” also has case reports of hepatotoxicity, including fatal outcomes. You should strongly advise patients with liver disease to avoid these supplements.
Oxalate nephropathy from chaga
Chaga grows as a parasitic canker on birch trees and is popular for its antioxidant claims. However, chaga contains extremely high levels of oxalates. Excessive consumption of chaga powder has led to acute oxalate nephropathy and kidney failure. Warn patients about this risk, especially those with a history of kidney stones or impaired renal function.
Shiitake dermatitis
Shiitake is a common culinary mushroom, but raw or undercooked shiitake can cause a severe skin reaction. Lentinan, a thermolabile compound in the cell wall, triggers shiitake dermatitis. This looks like whiplash marks on the trunk and limbs. Fortunately, cooking the mushroom at high temperatures inactivates the lentinan.
Common drug and disease interactions
Because non-psychedelic mushrooms contain active pharmacological compounds, they frequently interact with prescription medications.
Hypoglycemic agents
Many medicinal mushrooms decrease blood glucose levels. Agaricus blazei, chaga, lion’s mane, maitake, reishi, and turkey tail all show potential hypoglycemic effects. When patients take these alongside antidiabetes medications, they face a high risk of dangerous hypoglycemia. Educate your diabetic patients to monitor their blood sugar closely if they choose to try these supplements.
Anticoagulants and antiplatelets
Bleeding risks are another major concern. Chaga, lion’s mane, reishi, and cordyceps can inhibit platelet aggregation. When combined with warfarin, direct oral anticoagulants, or antiplatelet drugs, the risk of bleeding increases significantly. There is even a case report of maitake mushroom causing a highly elevated INR in a patient stabilized on warfarin. Always tell patients to stop taking these supplements well before any surgical procedures.
Immunosuppressants
Several non-psychedelic mushrooms stimulate the immune system. Black hoof, chaga, lion’s mane, and shiitake contain polysaccharides that enhance immune function. This can reduce the efficacy of immunosuppressant drugs used for organ transplants or autoimmune diseases like multiple sclerosis and rheumatoid arthritis. Advise these vulnerable patients to avoid immunostimulatory fungi to maintain their health.
Empower your pharmacy patients to safely navigate natural medicines
Your clinical knowledge is the best defense against adverse supplement events. When patients ask about non-psychedelic mushrooms, you now have the insights to guide them safely. Start by asking what they hope to achieve with the supplement, then review their current medication list for dangerous interactions like hypoglycemia or bleeding risks.
Encourage your patients to communicate openly about all the natural products they take. By providing clear, evidence-based advice, you can help them achieve their health goals safely and effectively. Keep expanding your knowledge on natural medicines so you can continue to be the trusted, accessible healthcare expert your community relies on.
